Meghmani Finechem Share Price
(EPIGRAL)
Check the latest share price of Meghmani Finechem, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
as on 02:41PM, 13 May 2025
NSE
Meghmani Finechem Performance
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
₹1,801.5Day's Price Range₹1,871.952 Week's Low
52 Week's High
₹1,110.0552-Week Price Range₹2,406.75
| Returns % | |
| 1 Month Return | + 0.29 % |
| 3 Month Return | -1.08 % |
| 1 Year Return | + 47.3 % |
| 3 Year Return | + 53.17 % |
| 5 Year Return | + 352.95 % |
| Market Stats | |
| Previous Close | ₹1,841.00 |
| Open | ₹1,834.30 |
| Volume | 28.54K |
| Upper Circuit | ₹2,209.20 |
| Lower Circuit | ₹1,472.80 |
Meghmani Finechem Fundamentals & Key Indicators
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹7,942.32 Cr
Return on Equity (ROE)
16.85
PE Ratio (TTM)
21.75
Return on capital employed (ROCE)
17.45
Industry PE ratio
54.11
Beta (LTM)
1.23
P/B Ratio
3.63
Dividend Yield
0.46
PEG Ratio
0.58
Quarterly Earnings Growth YOY
12.45
EPS (TTM)
47.14
Sector
Chemicals
Book Value
301.83
Technical Analysis
Bullish
View Technical Analysis
How to invest in Meghmani Finechem
Investing in Meghmani Finechem is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Meghmani Finechem or EPIGRAL on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Meghmani Finechem or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Meghmani Finechem with just a few clicks!
Meghmani Finechem Stock's Interest Amongst Investors
Meghmani Finechem Valuation
Track how the P/E of Meghmani Finechem has moved over time to understand valuation trends.
Meghmani Finechem in the last 5 years
Lowest (9.04x)
March 28, 2023
Today (21.75x)
May 12, 2025
Industry (54.11x)
May 12, 2025
Highest (38.05x)
September 24, 2024
Today’s Price to Earnings Ratio: 21.75x
Analysts Recommendation on Meghmani Finechem
Get updated buy, sell, and hold recommendations by analysts on Meghmani Finechem.
based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Meghmani Finechem. Average target price of ₹2450
Source: S&P Global Market Intelligence
Analysts Forecast on Meghmani Finechem
Get share price movements and forecasts by analysts on Meghmani Finechem.
Meghmani Finechem price forecast by 1 analysts
Upside of33.08%
High
₹2450
Target
₹2450.00
Low
₹2450
Meghmani Finechem target price ₹2450, a slight upside of 33.08% compared to current price of ₹1834.4. According to 1 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Meghmani Finechem revenue growth forecast
Expected growth rate Q1, FY2027:73.61%
Forecast
Actual
Including amortisation and stock based compensations
Meghmani Finechem EPS growth forecast
EPS estimate Q1, FY2027:43.71%
Forecast
Actual
Source: S&P Global Market Intelligence
Meghmani Finechem Financials
Get the annual and quarterly financial summary of Meghmani Finechem, including revenue, profit, loss and more.
Meghmani Finechem Index Inclusions
Meghmani Finechem Earnings and Dividends
View detailed summary of the earnings and dividend history of Meghmani Finechem.
Epigral Ltd Earnings Results
Epigral Ltd’s net profit jumped 12.45% since last year same period to ₹86.89Cr in the Q4 2024-2025. On a quarterly growth basis, Epigral Ltd has generated -16.15% fall in its net profits since last 3-months.
Read More about Earnings ResultsEpigral Ltd Dividends January,2025
In the quarter ending December 2024, Epigral Ltd has declared dividend of ₹2.50 - translating a dividend yield of 0.41%.
Read More about Dividends
Meghmani Finechem Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Meghmani Finechem.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 68.95% | 0.00 | |
| Foreign Institutions | 3.01% | 0.00 | |
| Mutual Funds | 4.48% | 0.00 | |
| Retail Investors | 23.35% | 0.00 | |
| Others | 0.21% | 0.00 |
Meghmani Finechem vs Peers
Compare market cap, revenue, PE, and other key metrics of Meghmani Finechem with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 7,942.32 | 70.59% | 0.71 | 195 | 1,929 | |
| NA | 1,519.62 | 640.07% | 0.50 | NA | NA | |
| NA | 635.10 | 8.61% | 0.75 | 4 | 190 | |
| NA | 2,152.79 | 263.41% | 0.84 | 57 | 593 | |
| BUY | 2,768.28 | 58.04% | 0.55 | 123 | 1,949 |
Meghmani Finechem News & Key Events
Latest news and events at one place to help you take investing decisions in Meghmani Finechem.
Emkay Global Financial Upgrades Epigral Target Price - 06 May, 2025
Emkay Global Financial maintains a 'BUY' rating on Epigral, raising the target price to Rs 2450. The company reported strong YoY growth in revenue, EBITDA, and PAT, driven by improvements in its caustic soda business and volume growth in derivatives. Capex plans are on track, with a volume growth guidance of 15-20% for the coming years.Epigral Reports Strong Q4 Results and Dividend - 05 May, 2025
Epigral's Q4 FY25 results show a 13% increase in net profit to Rs 87 crore, with total revenue rising 20% to Rs 631 crore. The company declared a final dividend of Rs 3.5 per share and plans to expand its CPVC and Epichlorohydrin capacity by FY2027, enhancing growth prospects.Epigral Ltd Expands Renewable Energy Initiatives - 23 Apr, 2025
Epigral Ltd is enhancing its renewable energy usage, sourcing 19 MW of solar and 19 MW of wind energy, meeting 15% of its energy needs. The company aims to increase this share to 25% within two years, highlighting its commitment to sustainability and competitiveness.
Insights on Epigral Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 4.15% to 4.48% in Mar 2025 quarter
- POSITIVE IMPACT
Promoter Holding Up
Promoters have increased holdings from 68.94% to 68.95% in Mar 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 1 year, EPIGRAL stock has moved up by 47.3%
NO EFFECTAgainst Peers
In the last 3 years, Solar Industries India Ltd has given 377.5% return, outperforming this stock by 324.3%
- NO EFFECT
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 3.01% of holdings in Mar 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Solar Industries India Ltd has given 53.2% return, outperforming this stock by 5.9%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 103.63 Cr → 86.89 Cr (in ₹), with an average decrease of 16.2% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 649.19 Cr → 631.3 Cr (in ₹), with an average decrease of 2.8% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 23.72% to 23.35% in Mar 2025 quarter
About Meghmani Finechem
Revenue: ₹627.63Cr as on March 2025 (Q1 25)
Net Profit: ₹86.89Cr as on March 2025 (Q1 25)
Listing date: 18 Aug, 2021
Chairperson Name: Maulik Jayantibhai Patel
| Organisation | Epigral Ltd |
| Headquarters | Ahmedabad |
| Industry | Chemicals |
| CEO | Maulik Jayantibhai Patel |
| E-voting on shares | Click here to vote |
Indian Mutual Funds that own Meghmani Finechem
Check out the Mutual Funds with significant holdings in Meghmani Finechem.
| Funds | Holdings | Prev. 5M |
|---|---|---|
| Bandhan Small Cap Fund Direct Growth | 0.51% | |
| HSBC Focused Fund Direct Growth | 3.07% | |
| HSBC Value Fund Direct Plan Growth Option | 0.33% | |
| HSBC Flexi Cap Fund Growth Direct | 0.9% | |
| HSBC Multi Cap Fund Direct Growth | 0.91% |
FAQs
What is Epigral Ltd price today?
Epigral Ltd share price today stands at ₹1834.4, Open: ₹1834.3, Previous Close: ₹1841, High: ₹1871.9, Low: ₹1801.5, 52 Week High: ₹2406.75, 52 Week Low: ₹1110.05.
How to Buy Epigral Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Epigral Ltd shares
What are today's traded volumes of Epigral Ltd?
Today's traded volume of Epigral Ltd(EPIGRAL) is 28.54K.
What is today's market capitalisation of Epigral Ltd?
Today's market capitalisation of Epigral Ltd(EPIGRAL) is ₹7,942.32 Cr.
What is the 52 Week High and Low Range of Epigral Ltd?
How much percentage Epigral Ltd is down from its 52 Week High?
Epigral Ltd (EPIGRAL) share price is ₹1834.4. It is down -23.78% from its 52 Week High price of ₹2406.75
How much percentage Epigral Ltd is up from its 52 Week low?
Epigral Ltd (EPIGRAL) share price is ₹1834.4. It is up 65.25% from its 52 Week Low price of ₹1110.05